GB2402212B - Detecting recurrence and high stage bladder carcinoma - Google Patents

Detecting recurrence and high stage bladder carcinoma

Info

Publication number
GB2402212B
GB2402212B GB0312205A GB0312205A GB2402212B GB 2402212 B GB2402212 B GB 2402212B GB 0312205 A GB0312205 A GB 0312205A GB 0312205 A GB0312205 A GB 0312205A GB 2402212 B GB2402212 B GB 2402212B
Authority
GB
United Kingdom
Prior art keywords
bladder carcinoma
high stage
stage bladder
detecting recurrence
recurrence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0312205A
Other versions
GB2402212A (en
GB0312205D0 (en
Inventor
Benjamin Yat Ming Yung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chang Gung University CGU
Original Assignee
Chang Gung University CGU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chang Gung University CGU filed Critical Chang Gung University CGU
Priority to GB0312205A priority Critical patent/GB2402212B/en
Publication of GB0312205D0 publication Critical patent/GB0312205D0/en
Publication of GB2402212A publication Critical patent/GB2402212A/en
Application granted granted Critical
Publication of GB2402212B publication Critical patent/GB2402212B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB0312205A 2003-05-28 2003-05-28 Detecting recurrence and high stage bladder carcinoma Expired - Fee Related GB2402212B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0312205A GB2402212B (en) 2003-05-28 2003-05-28 Detecting recurrence and high stage bladder carcinoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0312205A GB2402212B (en) 2003-05-28 2003-05-28 Detecting recurrence and high stage bladder carcinoma

Publications (3)

Publication Number Publication Date
GB0312205D0 GB0312205D0 (en) 2003-07-02
GB2402212A GB2402212A (en) 2004-12-01
GB2402212B true GB2402212B (en) 2007-04-11

Family

ID=9958873

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0312205A Expired - Fee Related GB2402212B (en) 2003-05-28 2003-05-28 Detecting recurrence and high stage bladder carcinoma

Country Status (1)

Country Link
GB (1) GB2402212B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8346485B2 (en) 2008-11-25 2013-01-01 Quest Diagnostics Investments Incorporated Methods and apparatuses for estimating initial target nucleic acid concentration in a sample by modeling background signal and cycle-dependent amplification efficiency of a polymerase chain reaction

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002082076A2 (en) * 2001-04-03 2002-10-17 Merck Patent Gmbh Renal cell carcinoma tumor markers

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002082076A2 (en) * 2001-04-03 2002-10-17 Merck Patent Gmbh Renal cell carcinoma tumor markers

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. Pathology 1996, 178(1), pp.48-52 - Nozawa et al. *

Also Published As

Publication number Publication date
GB2402212A (en) 2004-12-01
GB0312205D0 (en) 2003-07-02

Similar Documents

Publication Publication Date Title
GB2400667B (en) Attention detection
EP1664716A4 (en) Biomarkers in cancer
AU2003265364A8 (en) Transient detection circuit
IL164687A0 (en) Cellular libraries and methods for the preparationthereof
EP1811456A4 (en) Face feature point detector and feature point detector
EP1692378A4 (en) Turbo-charger surge detection
EP1551437A4 (en) Methods and compositions for detecting cancers
EP1767938A4 (en) Histamine detection method and histamine detection kit
HK1088837A1 (en) Clk-peptide and slk-peptide
PL376971A1 (en) Amplified genes involved in cancer
AU2003220387A8 (en) Gene amplification in cancer
AU2003271456A8 (en) Methods for detecting endocrine cancer
AU2003256705A8 (en) Metastatic colon cancer specific promoter and uses thereof
AU2003297434A8 (en) Portable basketball stand
AU2003276973A8 (en) Detection methods
GB0308070D0 (en) Integrated circuit design and testing
AU150845S (en) An impeller
GB2402212B (en) Detecting recurrence and high stage bladder carcinoma
GB0316910D0 (en) Fluorocombretastatin and derivatives thereof
AU2003228474A8 (en) Secretory signal sequences and uses thereof
ZA200606598B (en) Coumarin derivative and use thereof
GB0200110D0 (en) Cancer detection
TW566680U (en) Ring and line combined antenna
GB0405442D0 (en) Signal processing in multi-carrier CDMA
AU2003209265A8 (en) Mrp9 and its use detecting and treating cancer

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20090528